Combination therapy of IFNβ1 with lopinavir–ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients

Interferon Beta-1a (IFN-β1-a), an immunomodulatory mediator with antiviral effects, has shown in vivo and in vitro activities especially on coronavirus including SARS-CoV-2. COVID-19 defined as the disease caused by infection with SARS-CoV-2. The virus has been illustrated inhibits the production of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int Immunopharmacol
Päätekijät: Baghaei, Parvaneh, Dastan, Farzaneh, Marjani, Majid, Moniri, Afshin, Abtahian, Zahra, Ghadimi, Somayeh, Valizadeh, Melika, Heshmatnia, Jalal, Sadat Mirenayat, Maryam, Abedini, Atefeh, Kiani, Arda, Eslaminejad, Alireza, MohammadReza Hashemian, Seyed, Jamaati, Hamidreza, Zali, Alireza, Akbar Velayati, Ali, Tabarsi, Payam
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier B.V. 2021
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7762801/
https://ncbi.nlm.nih.gov/pubmed/33412395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.intimp.2020.107329
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia